Literature DB >> 29903923

MR Imaging Features of Anaplastic Pleomorphic Xanthoastrocytoma Mimicking High-Grade Astrocytoma.

D She1, J Liu1, Z Xing1, Y Zhang2, D Cao3, Z Zhang4.   

Abstract

BACKGROUND AND
PURPOSE: Anaplastic pleomorphic xanthoastrocytoma, which has been recently defined as a distinct entity in the 2016 World Health Organization classification, may exhibit aggressive clinical behavior and relatively worse prognosis than pleomorphic xanthoastrocytoma. This study aimed to investigate whether there were any differences in MR imaging characteristics between these 2 tumors.
MATERIALS AND METHODS: This retrospective study included 9 patients with anaplastic pleomorphic xanthoastrocytoma and 10 patients with pleomorphic xanthoastrocytoma who underwent MR imaging before an operation. DWI was performed in 17 patients (8 with anaplastic pleomorphic xanthoastrocytoma, 9 with pleomorphic xanthoastrocytoma); and DSC-PWI, in 9 patients (5 with anaplastic pleomorphic xanthoastrocytoma, 4 with pleomorphic xanthoastrocytoma). Demographics, conventional imaging characteristics (location, size, cystic degeneration, enhancement, peritumoral edema, and leptomeningeal contact), minimum relative ADC ratio, and maximum relative CBV ratio were evaluated between the anaplastic pleomorphic xanthoastrocytoma and pleomorphic xanthoastrocytoma groups.
RESULTS: Anaplastic pleomorphic xanthoastrocytoma was more likely to demonstrate high-grade features than pleomorphic xanthoastrocytoma, including greater maximum tumor diameter (4.7 ± 0.6 cm versus 3.1 ± 1.1 cm, P = .001), more frequent heterogeneous contrast enhancement of solid portions (88.9% versus 20.0%, P = .01), more obvious peritumoral edema (2.3 ± 0.9 cm versus 1.0 ± 0.9 cm, P = .008), lower minimum relative ADC on DWI (1.0 ± 0.2 versus 1.5 ± 0.4, P = .008), and higher maximum relative CBV on DSC-PWI (2.6 ± 0.8 versus 1.6 ± 0.2, P = .036).
CONCLUSIONS: Anaplastic pleomorphic xanthoastrocytomas often have more aggressive MR imaging features mimicking high-grade astrocytomas than pleomorphic xanthoastrocytomas. DWI and DSC-PWI might be useful in the characterization and differentiation of anaplastic pleomorphic xanthoastrocytoma and pleomorphic xanthoastrocytoma.
© 2018 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2018        PMID: 29903923     DOI: 10.3174/ajnr.A5701

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  8 in total

1.  Anaplastic Pleomorphic Xanthoastrocytoma: A Rare Variant of Astrocytoma.

Authors:  Khalilalrahman Alshantti; Chandran Nadarajan; Mitchell Modi Mijol; Anani Aila Mat Zin
Journal:  Cureus       Date:  2022-03-11

2.  Differences in treatment patterns and overall survival between grade II and anaplastic pleomorphic xanthoastrocytomas.

Authors:  Adrian Rodrigues; Hriday Bhambhvani; Zachary A Medress; Shreya Malhotra; Melanie Hayden-Gephart
Journal:  J Neurooncol       Date:  2021-05-10       Impact factor: 4.130

Review 3.  Radiohistogenomics of pediatric low-grade neuroepithelial tumors.

Authors:  Asim K Bag; Jason Chiang; Zoltan Patay
Journal:  Neuroradiology       Date:  2021-03-29       Impact factor: 2.804

4.  Identification of BRAF p. V600E-Mutant and Wild-Type by MR Imaging in Pleomorphic Xanthoastrocytoma and Anaplastic Pleomorphic Xanthoastrocytoma.

Authors:  W Huang; J Cai; N Lin; Y Xu; H Wang; Z Wu; D Kang
Journal:  AJNR Am J Neuroradiol       Date:  2021-11-01       Impact factor: 3.825

5.  Anaplastic Pleomorphic Xanthoastrocytoma Presenting with Musical Hallucination.

Authors:  Oreoluwa Oladiran; Ifeanyi Nwosu; Steve Obanor; Chinyere Ogbonna-Nwosu; Brian Le
Journal:  Case Rep Neurol Med       Date:  2018-11-11

6.  A case series of pediatric survivors of anaplastic pleomorphic xanthoastrocytoma.

Authors:  Rebecca Ronsley; Christopher Dunham; Stephen Yip; Lindsay Brown; Jeffrey A Zuccato; Shirin Karimi; Gelareh Zadeh; Karen Goddard; Ash Singhal; Juliette Hukin; Sylvia Cheng
Journal:  Neurooncol Adv       Date:  2021-01-30

7.  Malignant transformation of pleomorphic xanthoastrocytoma in pregnant patient: Clinical case and ethical dilemma.

Authors:  Jurica Marakovic; Darko Chudy; Danko Muller; Damir Tomac; Petar Marcinkovic; Darko Oreskovic; Andjelo Kastelancic; Marina Raguz
Journal:  Surg Neurol Int       Date:  2021-09-20

Review 8.  Nanomedicine in Clinical Photodynamic Therapy for the Treatment of Brain Tumors.

Authors:  Hyung Shik Kim; Dong Yun Lee
Journal:  Biomedicines       Date:  2022-01-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.